Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raju Subramanian

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 DiabetesAiwen Li, Chester C Yuan, David Chow, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2018
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical DevelopmentJim Zheng, Yan Xin, Jingyu Zhang, et al.
Chemical Research in Toxicology|June 21, 2005
Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugatesCuyue Tang, Raju Subramanian, Yuhsin Kuo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2016
Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel d-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide)Raju Subramanian, Xiaochun Zhu, Savannah J Kerr, et al.
International Journal of Toxicology|March 5, 2016
Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary HyperparathyroidismMark R Fielden, Charles Dean, Kurt Black, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 26, 2023
Human pharmacokinetics prediction with an <i>in vitro</i>-<i>in vivo</i> correction factor approach and <i>in vitro</i> drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy<sup>®</sup> for the treatment of HIV-1 infectionRaju Subramanian, Jianhong Wang, Bernard Murray, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 28, 2014
P450-mediated O-demethylated metabolite is responsible for rat hepatobiliary toxicity of pyridyltriazine-containing PI3K inhibitorsRaju Subramanian, Divesh Aidasani, Keith Bailey, et al.
Viruses|June 27, 2025
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?Darius Babusis, Cynthia Kim, Jesse Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2006
Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteersStacey L Polsky-Fisher, Stanley Vickers, Donghui Cui, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2024
Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core proteinDmytro Kornyeyev, Zhijuan Song, Stacey Eng, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 DiabetesAiwen Li, Chester C Yuan, David Chow, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2018
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical DevelopmentJim Zheng, Yan Xin, Jingyu Zhang, et al.
Chemical Research in Toxicology|June 21, 2005
Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugatesCuyue Tang, Raju Subramanian, Yuhsin Kuo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2016
Nonclinical Pharmacokinetics, Disposition, and Drug-Drug Interaction Potential of a Novel d-Amino Acid Peptide Agonist of the Calcium-Sensing Receptor AMG 416 (Etelcalcetide)Raju Subramanian, Xiaochun Zhu, Savannah J Kerr, et al.
International Journal of Toxicology|March 5, 2016
Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary HyperparathyroidismMark R Fielden, Charles Dean, Kurt Black, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 26, 2023
Human pharmacokinetics prediction with an <i>in vitro</i>-<i>in vivo</i> correction factor approach and <i>in vitro</i> drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy<sup>®</sup> for the treatment of HIV-1 infectionRaju Subramanian, Jianhong Wang, Bernard Murray, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 28, 2014
P450-mediated O-demethylated metabolite is responsible for rat hepatobiliary toxicity of pyridyltriazine-containing PI3K inhibitorsRaju Subramanian, Divesh Aidasani, Keith Bailey, et al.
Viruses|June 27, 2025
Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?Darius Babusis, Cynthia Kim, Jesse Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2006
Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteersStacey L Polsky-Fisher, Stanley Vickers, Donghui Cui, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2024
Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core proteinDmytro Kornyeyev, Zhijuan Song, Stacey Eng, et al.
Pageof 8